Publications
- Why do guidelines for the treatment of metastatic panrceate cancer end after the first / second line?2021 | Publication without faculty affiliation
- Metastatický kolorektální karcinom u starších pacientů - léčebná doporučení Francouzské společnosti pro geriatrickou onkologii (SoFOG)2020 | Publication without faculty affiliation
- Nová indikace pro trifluridin/tipiracil: léčba metastatického karcinomu žaludku2019 | Publication without faculty affiliation
- Recent advances in immunotherapy for metastatic colorectal cancer2023 | Publication without faculty affiliation
- The role of vaccines in the prevention and treatment of head and neck cancer2022 | Publication without faculty affiliation
- PD-1 inhibitors in the treatment of advanced esophageal cancer2021 | Publication without faculty affiliation
- Panitumumab in the first-line treatment of elderly patients - results of the PANDA study2021 | Publication without faculty affiliation
- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- High microsatellite instability in gastric cancer is an important biomarker of sensitivity to immunotherapy2021 | Publication without faculty affiliation
- Differences in the determination of DNA mismatch repair deficit using molecular and immunohistochemical methods2021 | Publication without faculty affiliation
Loading network view...